Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.


Fisher B. A., Mariette X., Papas A., Grader-Beck T., Bootsma H., Ng W., ...Daha Fazla

Lancet (London, England), cilt.404, sa.10452, ss.540-553, 2024 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 404 Sayı: 10452
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1016/s0140-6736(24)01211-x
  • Dergi Adı: Lancet (London, England)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.540-553
  • Gazi Üniversitesi Adresli: Evet